“…As indicated above, this approach improves tissue oxygenation despite the reduced concentration of erythrocytes (Dittrich et al, 2000). Reported diluents have been cell free solutions (Domingo-Pech et al, 1991;Wagner et al, 2003;Erasmus et al, 2006;Friebe et al, 2013b) or autologous plasma (Patan et al, 2009;Patan-Zugaj et al, 2012, which comes with the added benefit of increasing oncotic pressure. As cell free solutions are associated with low oncotic pressure, resulting in edema formation and weight gain, adding plasma expanders such as plasma proteins (Verbeke et al, 1968;Roets et al, 1974;Patan et al, 2009) and purified albumin (Rehfeld et al, 1982;Barthel et al, 1989;Riviere et al, 1989;Brunicardi et al, 2001) perfused specimens thus reflects the degree of ischemia/reperfusion injury (Petrasek et al, 1994;Adham et al, 1997) and the integrity of the microvasculature (Müller et al, 2013).…”